$1.620
+0.383 (+23.66%)Zum Schluss
DAVI im Vergleich zur Peergroup
In the context of the broader market, DAVI competes directly with industry leaders such as HBIO and SNWV. With a market capitalization of $40.50M, it holds a leading position in the sector. When comparing efficiency, DAVI's gross margin of N/A stands against HBIO's 51.96% and SNWV's 73.65%. Such benchmarking helps identify whether Davion Healthcare Plc is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Davion Healthcare Plc Ordinary Shares
The company has a P/E ratio of 0 and a forward P/E of 0, indicating no earnings at this time. The price-to-sales and price-to-free cash flow ratios are also 0, which suggests that the company is not generating revenue or cash flow effectively.
Financials
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.